Healthcare Business - Page 2

Why Tonix Pharma Shares Are Skyrocketing

Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) shares were up sharply on Thursday after the company announced an update from the U.S. Food and Drug Administration (FDA). Essentially, the minutes from ...
Read Full Story »

Moderna Announces Potential Pricing for IPO

Moderna has filed an amended S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). The company intends to price its 21.74 million shares ...
Read Full Story »

Short Sellers Hike Their Bets in Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Biotechs

The short interest data are out for the most recent settlement date, November 15. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »

Catabasis Wins With Early-Stage Duchenne Muscular Dystrophy Study

Catabasis Pharmaceuticals Inc. (NASDAQ: CATB) shares made a handy gain on Tuesday after the company announced early stage data from its Duchenne muscular dystrophy (DMD) study. The company announced that ...
Read Full Story »

Rocket Pharma Grounded Despite Positive FDA Update

Rocket Pharmaceuticals Inc. (NASDAQ: RCKT) shares dipped on Tuesday after the company shared an update from the U.S. Food and Drug Administration (FDA). While the update wasn’t negative, this seems ...
Read Full Story »

Bristol-Myers Loses Out in Late-Stage Lung Cancer Study

Bristol-Myers Squibb Co. (NYSE: BMY) shares dipped on Tuesday after the company reported results from its late-stage lung cancer study. The firm announced that its Phase 3 CheckMate 451 study ...
Read Full Story »

Why Wedbush Is Staying Positive on Zafgen

Zafgen Inc. (NASDAQ: ZFGN) shares were absolutely stomped on Monday after the company announced that the U.S. Food and Drug Administration (FDA) had put a clinical hold on its Investigational ...
Read Full Story »

Why Zafgen Shares Got Stomped

Zafgen Inc. (NASDAQ: ZFGN) shares were absolutely crushed on Monday after the company announced an update from the U.S. Food and Drug Administration (FDA). Essentially, the FDA put a clinical ...
Read Full Story »

Why One Top Drug Stock Could Have Nearly 30% Upside

Mallinckrodt PLC (NYSE: MNK) has been a prominent player in the health care industry and while most analysts are taking a middle-of-the-road approach to the company, one has come out ...
Read Full Story »

Canaccord Genuity’s Top Biopharma Catalysts Coming This Quarter

Companies in the health care sector face great risk and great reward every time they make an announcement. Drug candidates passing clinical trials, gaining regulatory approval or being canceled can ...
Read Full Story »

Seattle Genetics Dips Despite FDA Win

Seattle Genetics Inc. (NASDAQ: SGEN) shares dipped on Monday following an update from the U.S. Food and Drug Administration (FDA). Essentially, the FDA granted Breakthrough Therapy Designation to Adcetris (brentuximab ...
Read Full Story »

Why Arena Pharma Is Winning Big With Its New Collaboration

Arena Pharmaceuticals Inc. (NASDAQ: ARNA) shares jumped early on Thursday after the company announced a new global license agreement with United Therapeutics Corp. (NASDAQ: UTHR). The goal of this collaboration ...
Read Full Story »

Synthorx Gears Up for IPO

Synthorx has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were given in the filing, although the ...
Read Full Story »

Short Sellers Raise the Stakes in Major Biotechs

The short interest data are out for the most recent settlement date, October 31. Generally speaking, companies within the biotech industry are considered to be a riskier group of stocks, ...
Read Full Story »